Recent Therapeutic Advances in Pituitary Carcinoma
Pituitary carcinoma (PC) is a rare, aggressive malignancy that comprises 0.1–0.2% of all pituitary tumors. PC is defined anatomically as a pituitary tumor that metastasizes outside the primary intrasellar location as noncontiguous lesions in the central nervous system or as metastases to other organ...
Main Authors: | Ian J. Robertson, Timothy A. Gregory, Steven G. Waguespack, Marta Penas-Prado, Nazanin K. Majd |
---|---|
Format: | Article |
Language: | English |
Published: |
Innovative Healthcare Institute
2023-05-01
|
Series: | Journal of Immunotherapy and Precision Oncology |
Subjects: | |
Online Access: | https://jipo.org/doi/pdf/10.36401/JIPO-22-25 |
Similar Items
-
Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain
by: Cristina Lamas, et al.
Published: (2023-08-01) -
Exploring the Role of Novel Medical Therapies for Aggressive Pituitary Tumors: A Review of the Literature—“Are We There Yet?”
by: Lydia S. Lamb, et al.
Published: (2020-01-01) -
Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art
by: Tiziana Feola, et al.
Published: (2022-08-01) -
The Microenvironment of Pituitary Tumors—Biological and Therapeutic Implications
by: Mirela Diana Ilie, et al.
Published: (2019-10-01) -
Pituitary carcinoma - case series and review of the literature
by: Stephanie Du Four, et al.
Published: (2022-09-01)